SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000069499-07-000001
Filing Date
2007-01-09
Accepted
2007-01-09 17:29:58
Documents
1
Period of Report
2007-01-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1491
  Complete submission text file 0000069499-07-000001.txt   3426
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Issuer) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 724-514-1800
Nimmagadda Prasad (Reporting) CIK: 0001380962 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-09114 | Film No.: 07521318